- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
- 10-K Annual report
- 10.49 Board of Director's Compensation Structure
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification by the Chief Executive Officer
- 31.2 Certification by the Chief Financial Officer
- 32.1 Certification by the Chief Executive Officer
- 32.2 Certifications by the Chief Financial Officer
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-110942) and on Form S-8 (Nos. 333-116675, 333-96771, 333-41801, 333-63604, 333-61497 and 333-47586) of Salix Pharmaceuticals, Ltd., and in the related prospectus of our reports dated March 11, 2005, with respect to the consolidated financial statements and schedule of Salix Pharmaceuticals, Ltd., Salix Pharmaceuticals, Ltd. management’s assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of Salix Pharmaceuticals, Ltd, included in the Annual Report (Form 10-K) for the year ended December 31, 2004.
Raleigh, North Carolina
March 11, 2005